Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 2/20 | 0.57 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CTSV | O60911 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.43 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26908096 | 0.90 | GLRA1 (0.56) | GLRA1PTGER1ALDH1A1LMNAHPGD | |
| SCHEMBL8408603 | 0.87 | ALDH1A1 (0.54) | GLRA1ALDH1A1LMNAHPGDKMT2A | |
| SCHEMBL21338330 | 0.87 | ALDH1A1 (0.47) | GLRA1PTGER1ALDH1A1CTSVCTSL | |
| SCHEMBL28616880 | 0.84 | KMT2A (0.43) | ALDH1A1LMNAHPGDMEN1KMT2A | |
| SCHEMBL15716510 | 0.84 | ALDH1A1 (0.58) | PTGER1ALDH1A1CTSVCTSLLMNA | |
| SCHEMBL28078446 | 0.84 | GLRA1 (0.60) | GLRA1ALDH1A1LMNAHPGD | |
| SCHEMBL28061345 | 0.84 | GLRA1 (0.50) | GLRA1PTGER1ALDH1A1LMNAHPGD | |
| SCHEMBL28060114 | 0.82 | GLRA1 (0.60) | GLRA1ALDH1A1LMNAHPGDFFAR1 | |
| SCHEMBL28060142 | 0.82 | GLRA1 (0.60) | GLRA1ALDH1A1LMNAHPGDFFAR1 | |
| SCHEMBL28060106 | 0.82 | GLRA1 (0.60) | GLRA1ALDH1A1LMNAHPGDFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1866033-B1 | SUNSCREEN AEROSOL SPRAY | ENSIGN LABORATORIES PTY LTD (AU) | 2017-04-19 | — | — | EP | claimed |
| EP-1594454-B1 | FILM FORMING HYDROALCOHOLIC FOAM | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2016-07-27 | — | — | EP | claimed |
| EP-1595936-B1 | COMPOSITION FOR EXTERNAL USE | VITAMIN C60 BIORES CORP (JP) | 2011-10-19 | — | — | EP | claimed |
| US-7691403-B2 | Non-absorbent tampon containing additives inhibiting TSST-1 | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-04-06 | — | — | US | claimed |
| EP-1641443-B1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING DIMTHYLSULPHONE AND A SUNSCREEN FOR THE CURE AND PREVENTION OF IRRITATION, INFLAMMATION AND CUTANEOUS ERYTHEMA | DE PAOLI AMBROSI GIANFRANCO (IT) | 2009-01-14 | — | — | EP | claimed |
| US-20080096850-A1 | Exposing Grampositive bacteria of vagina to a synergistic mixture including hexachlorophene, benzyl paraben, benzyl salicylate, a benzophenone, chlorophene, 2,4-diaminodiphenylamine, dichlorophene, HC Green No. 1, HC Orange No. 1, HC Red No. 1, isopropylbenzyl salicylate, and phenyl salicylate; tampons | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-04-24 | — | — | US | claimed |
| US-7118759-B2 | Absorbent articles containing additives | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2006-10-10 | — | — | US | claimed |
| US-20030165559-A1 | Non-absorbent articles containing additives | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-09-04 | — | — | US | claimed |
| US-20030158156-A1 | Methods for inhibiting the production of TSST-1 | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-21 | — | — | US | claimed |
| US-20030157149-A1 | Menstrual tampons comprising cerulenin, triclosan, or hexachlorophene to inhibit production of toxic shock syndrome toxins by gram-positive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-21 | — | — | US | claimed |
| US-11585750-B2 | Arrangement for determining body surface properties by means of Multiple Spatially Resolved Reflection Spectroscopy (MSRRS) | HENKEL AG & CO. KGAA (DE) | 2023-02-21 | — | — | US | disclosed |
| US-20200300754-A1 | ARRANGEMENT FOR DETERMINING BODY SURFACE PROPERTIES BY MEANS OF MULTIPLE SPATIALLY RESOLVED REFLECTION SPECTROSCOPY (MSRRS) | HENKEL AG & CO. KGAA (DE) | 2020-09-24 | — | — | US | disclosed |
| EP-3707725-A1 | ARRANGEMENT FOR DETERMINING BODY SURFACE PROPERTIES BY MEANS OF MULTIPLE SPATIALLY RESOLVED REFLECTION SPECTROSCOPY (MSRRS) | Henkel AG & Co. KGaA (DE) | 2020-09-16 | — | — | EP | disclosed |
| EP-3106147-B1 | METHOD FOR PRODUCING POLYMERS OF ACRYLOYLDIMETHYL TAURATE, NEUTRAL MONOMERS, MONOMERS WITH CARBOXYLIC ACIDS AND SPECIAL CROSSLINKING AGENTS | CLARIANT INT LTD (CH) | 2019-09-04 | — | — | EP | disclosed |
| EP-3217981-B1 | COSMETIC COMPOSITION, ITS PROPHYLACTIC USE AND IN TREATMENT OF SKIN IMPURITIES, OF SKIN SUSCEPTIBLE TO ACNE AND ACNE | Cosmedes GmbH (DE) | 2019-07-31 | — | — | EP | disclosed |
| US-5744062-A | CONTROLLING VISCOSITY | R.I.T.A. CORPORATION (US) | 1998-04-28 | — | — | US | disclosed |
| WO-1998008597-A1 | EMULSIFIER BLENDS FOR OIL-IN-WATER EMULSIONS | R.I.T.A. CORPORATION (US) | 1998-03-05 | — | — | WO | disclosed |
| WO-1998005294-A1 | AN OIL-IN-WATER EMULSION FOR USE ON HUMAN SKIN FOR CLEANSING, PRESERVING OR IMPROVING THE CONDITION OF THE SKIN | PLUM KEMI PRODUKTION A/S (DK) | 1998-02-12 | — | — | WO | disclosed |
| EP-0778821-A1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LIMITED (GB) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996006822-A1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LIMITED (GB) | 1996-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096850-A1 | Exposing Grampositive bacteria of vagina to a synergistic mixture including hexachlorophene, benzyl paraben, benzyl salicylate, a benzophenone, chlorophene, 2,4-diaminodiphenylamine, dichlorophene, HC Green No. 1, HC Orange No. 1, HC Red No. 1, isopropylbenzyl salicylate, and phenyl salicylate; tampons | TST, DDT, SULT1E1 | GLRA1 2113/4885PTGER1 823/4885ALDH1A1 387/4885 |
| US-20030158156-A1 | Methods for inhibiting the production of TSST-1 | TST, TSSK1B, DNTT | GLRA1 2581/4885PTGER1 3201/4885ALDH1A1 3495/4885 |
| US-20030165559-A1 | Non-absorbent articles containing additives | CNOT1, DCUN1D1, CNDP2 | GLRA1 2905/4885PTGER1 3765/4885ALDH1A1 3289/4885 |
| US-20030157149-A1 | Menstrual tampons comprising cerulenin, triclosan, or hexachlorophene to inhibit production of toxic shock syndrome toxins by gram-positive bacteria | TPSAB1, TPT1, TST | GLRA1 4103/4885PTGER1 1522/4885ALDH1A1 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.